[(3S)-1-[3-[[1-[1-[[3-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)benzoyl]-3-azaspiro[5.5]undecan-9-yl]methyl]piperidin-4-yl]-3-(difluoromethyl)pyrazol-4-yl]carbamoyl]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-3-yl] 2,2-dimethylpropanoate
C48H60ClF2N11O6 — CID 175860353
Data last refreshed: (MolForge compound catalog, from PubChem)
About [(3S)-1-[3-[[1-[1-[[3-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)benzoyl]-3-azaspiro[5.5]undecan-9-yl]methyl]piperidin-4-yl]-3-(difluoromethyl)pyrazol-4-yl]carbamoyl]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-3-yl] 2,2-dimethylpropanoate
[(3S)-1-[3-[[1-[1-[[3-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)benzoyl]-3-azaspiro[5.5]undecan-9-yl]methyl]piperidin-4-yl]-3-(difluoromethyl)pyrazol-4-yl]carbamoyl]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-3-yl] 2,2-dimethylpropanoate (PubChem CID 175860353) has the molecular formula C48H60ClF2N11O6 and a molecular weight of 960.53 g/mol. Its IUPAC name is [(3S)-1-[3-[[1-[1-[[3-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)benzoyl]-3-azaspiro[5.5]undecan-9-yl]methyl]piperidin-4-yl]-3-(difluoromethyl)pyrazol-4-yl]carbamoyl]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-3-yl] 2,2-dimethylpropanoate.
Molecular Properties
| Compound Name | [(3S)-1-[3-[[1-[1-[[3-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)benzoyl]-3-azaspiro[5.5]undecan-9-yl]methyl]piperidin-4-yl]-3-(difluoromethyl)pyrazol-4-yl]carbamoyl]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-3-yl] 2,2-dimethylpropanoate |
|---|---|
| PubChem CID | 175860353 |
| Molecular Formula | C48H60ClF2N11O6 |
| Molecular Weight | 960.53 g/mol |
| Exact Mass | 959.44 |
| IUPAC Name | [(3S)-1-[3-[[1-[1-[[3-[4-chloro-3-(2,4-dioxo-1,3-diazinan-1-yl)benzoyl]-3-azaspiro[5.5]undecan-9-yl]methyl]piperidin-4-yl]-3-(difluoromethyl)pyrazol-4-yl]carbamoyl]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-3-yl] 2,2-dimethylpropanoate |
| SMILES | CC(C)(C)C(=O)O[C@H]1CCCN(c2ccn3ncc(C(=O)Nc4cn(C5CCN(CC6CCC7(CC6)CCN(C(=O)c6ccc(Cl)c(N8CCC(=O)NC8=O)c6)CC7)CC5)nc4C(F)F)c3n2)C1 |
| InChI | InChI=1S/C48H60ClF2N11O6/c1-47(2,3)45(66)68-33-5-4-18-59(28-33)38-12-22-61-42(54-38)34(26-52-61)43(64)53-36-29-62(56-40(36)41(50)51)32-10-19-57(20-11-32)27-30-8-14-48(15-9-30)16-23-58(24-17-48)44(65)31-6-7-35(49)37(25-31)60-21-13-39(63)55-46(60)67/h6-7,12,22,25-26,29-30,32-33,41H,4-5,8-11,13-21,23-24,27-28H2,1-3H3,(H,53,64)(H,55,63,67)/t33-/m0/s1 |
| InChIKey | YLSIELFTZVNQOI-XIFFEERXSA-N |
| XLogP | 7.52 |
| TPSA | 179.61 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 13 |
| Rotatable Bonds | 10 |
| Heavy Atoms | 68 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 960.53 |
| LogP ≤ 5 | 7.52 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 13 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 175860353 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.